Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasco Miranda

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Nephrology|September 26, 2012
Main determinants of PON1 activity in hemodialysis patientsSandra Ribeiro, Maria do Sameiro Faria, Filipa Mascarenhas-Melo, et al.
Mediators of Inflammation|July 19, 2019
Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause MortalityMaria João Valente, Susana Rocha, Susana Coimbra, et al.
Renal Failure|July 13, 2019
Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patientsLuís Belo, Susana Rocha, Maria João Valente, et al.
Scientific Reports|July 21, 2021
Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysisSusana Rocha, Maria João Valente, Susana Coimbra, et al.
Clinical Kidney Journal|May 7, 2021
Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysisSusana Coimbra, Susana Rocha, Henrique Nascimento, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 31, 2016
Risk factors for mortality in end-stage kidney disease patients under online-hemodiafiltration: three-year follow-up studyPedro de Sousa-Martins, Alexandra Moura, José Madureira, et al.
Disease Markers|December 19, 2013
Risk factors for mortality in hemodialysis patients: two-year follow-up studyMaria do Sameiro-Faria, Sandra Ribeiro, Elísio Costa, et al.
Oxidative Medicine and Cellular Longevity|March 27, 2019
The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass IndexSusana Coimbra, Flávio Reis, Sara Nunes, et al.
International Journal of Molecular Sciences|March 28, 2024
Age-Related Changes in Clinical and Analytical Variables in Chronic Hemodialyzed PatientsLuís Belo, Maria João Valente, Susana Rocha, et al.
Biomedicines|May 16, 2023
The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on DialysisSusana Coimbra, Cristina Catarino, Maria Sameiro Faria, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Nephrology|September 26, 2012
Main determinants of PON1 activity in hemodialysis patientsSandra Ribeiro, Maria do Sameiro Faria, Filipa Mascarenhas-Melo, et al.
Mediators of Inflammation|July 19, 2019
Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause MortalityMaria João Valente, Susana Rocha, Susana Coimbra, et al.
Renal Failure|July 13, 2019
Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patientsLuís Belo, Susana Rocha, Maria João Valente, et al.
Scientific Reports|July 21, 2021
Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysisSusana Rocha, Maria João Valente, Susana Coimbra, et al.
Clinical Kidney Journal|May 7, 2021
Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysisSusana Coimbra, Susana Rocha, Henrique Nascimento, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 31, 2016
Risk factors for mortality in end-stage kidney disease patients under online-hemodiafiltration: three-year follow-up studyPedro de Sousa-Martins, Alexandra Moura, José Madureira, et al.
Disease Markers|December 19, 2013
Risk factors for mortality in hemodialysis patients: two-year follow-up studyMaria do Sameiro-Faria, Sandra Ribeiro, Elísio Costa, et al.
Oxidative Medicine and Cellular Longevity|March 27, 2019
The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass IndexSusana Coimbra, Flávio Reis, Sara Nunes, et al.
International Journal of Molecular Sciences|March 28, 2024
Age-Related Changes in Clinical and Analytical Variables in Chronic Hemodialyzed PatientsLuís Belo, Maria João Valente, Susana Rocha, et al.
Biomedicines|May 16, 2023
The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on DialysisSusana Coimbra, Cristina Catarino, Maria Sameiro Faria, et al.
Pageof 6